111, Inc. (NASDAQ:YI) Sees Large Decline in Short Interest

111, Inc. (NASDAQ:YI) was the target of a large drop in short interest during the month of February. As of February 15th, there was short interest totalling 6,100 shares, a drop of 74.3% from the January 31st total of 23,700 shares. Approximately 0.1% of the company’s shares are sold short. Based on an average daily trading volume, of 34,900 shares, the days-to-cover ratio is currently 0.2 days.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of 111 in a report on Wednesday, February 19th.

111 Stock Up 0.2 %

Shares of 111 stock opened at $8.87 on Friday. The stock has a market cap of $75.86 million, a price-to-earnings ratio of -2.22 and a beta of 0.41. 111 has a twelve month low of $4.15 and a twelve month high of $15.80. The company’s fifty day moving average is $6.46 and its 200 day moving average is $7.32.

111 (NASDAQ:YI) last posted its quarterly earnings data on Wednesday, November 27th. The company reported ($0.20) earnings per share for the quarter.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. JPMorgan Chase & Co. increased its stake in 111 by 43,619.9% in the fourth quarter. JPMorgan Chase & Co. now owns 306,039 shares of the company’s stock valued at $191,000 after purchasing an additional 305,339 shares in the last quarter. Napean Trading & Investment Co Singapore PTE Ltd acquired a new stake in shares of 111 in the 4th quarter valued at about $245,000. Finally, FIL Ltd bought a new stake in 111 in the 4th quarter valued at about $450,000. 21.32% of the stock is owned by institutional investors.

About 111

111, Inc engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies.